Grey Wolf Animal Health Corp.
WOLF.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 19.33M | 19.14M | 18.85M | 18.83M | 18.38M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.33M | 19.14M | 18.85M | 18.83M | 18.38M |
| Cost of Revenue | 9.43M | 9.42M | 9.38M | 9.33M | 9.07M |
| Gross Profit | 9.90M | 9.72M | 9.47M | 9.51M | 9.31M |
| SG&A Expenses | 7.61M | 7.59M | 7.57M | 7.43M | 7.22M |
| Depreciation & Amortization | 780.10K | 803.60K | 827.10K | 847.00K | 847.60K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.82M | 17.82M | 17.78M | 17.60M | 17.13M |
| Operating Income | 1.51M | 1.32M | 1.07M | 1.23M | 1.25M |
| Income Before Tax | 1.16M | 936.50K | 670.40K | 818.40K | 4.85M |
| Income Tax Expenses | 482.30K | 418.90K | 425.60K | 363.60K | -84.20K |
| Earnings from Continuing Operations | 0.68 | 0.52 | 0.24 | 0.45 | 4.93 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 675.10K | 517.50K | 244.60K | 454.60K | 4.93M |
| EBIT | 1.51M | 1.32M | 1.07M | 1.23M | 1.25M |
| EBITDA | 2.45M | 2.26M | 2.01M | 2.17M | 2.18M |
| EPS Basic | 0.02 | 0.02 | 0.01 | 0.01 | 0.29 |
| Normalized Basic EPS | 0.02 | 0.02 | 0.01 | 0.02 | 0.17 |
| EPS Diluted | 0.02 | 0.02 | 0.01 | 0.01 | 0.29 |
| Normalized Diluted EPS | 0.02 | 0.02 | 0.01 | 0.02 | 0.17 |
| Average Basic Shares Outstanding | 121.48M | 121.48M | 121.48M | 121.48M | 108.76M |
| Average Diluted Shares Outstanding | 121.48M | 121.48M | 121.48M | 121.48M | 108.76M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
